Wells Fargo’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$105M Buy
321,824
+21,744
+7% +$7.09M 0.02% 533
2025
Q1
$81M Buy
300,080
+23,118
+8% +$6.24M 0.02% 567
2024
Q4
$65.2M Buy
276,962
+10,465
+4% +$2.46M 0.01% 642
2024
Q3
$73.3M Buy
266,497
+60,349
+29% +$16.6M 0.02% 601
2024
Q2
$50.1M Sell
206,148
-216
-0.1% -$52.5K 0.01% 722
2024
Q1
$30.8M Sell
206,364
-23,266
-10% -$3.48M 0.01% 905
2023
Q4
$44M Sell
229,630
-36,105
-14% -$6.91M 0.01% 740
2023
Q3
$47.1M Buy
265,735
+6,705
+3% +$1.19M 0.01% 673
2023
Q2
$49.2M Buy
259,030
+14,564
+6% +$2.77M 0.01% 686
2023
Q1
$49M Buy
244,466
+45,050
+23% +$9.02M 0.01% 678
2022
Q4
$47.4M Buy
199,416
+135,604
+213% +$32.2M 0.01% 668
2022
Q3
$12.8M Sell
63,812
-8,996
-12% -$1.8M ﹤0.01% 1283
2022
Q2
$10.6M Buy
72,808
+8,499
+13% +$1.24M ﹤0.01% 1471
2022
Q1
$10.5M Buy
64,309
+19,142
+42% +$3.13M ﹤0.01% 1720
2021
Q4
$7.66M Sell
45,167
-91,083
-67% -$15.4M ﹤0.01% 2002
2021
Q3
$25.7M Sell
136,250
-10,570
-7% -$2M 0.01% 1427
2021
Q2
$24.9M Sell
146,820
-8,690
-6% -$1.47M 0.01% 1482
2021
Q1
$22M Sell
155,510
-63,066
-29% -$8.9M ﹤0.01% 1560
2020
Q4
$28.4M Sell
218,576
-31,029
-12% -$4.03M 0.01% 1303
2020
Q3
$36.3M Buy
249,605
+7,659
+3% +$1.12M 0.01% 1024
2020
Q2
$35.8M Sell
241,946
-7,388
-3% -$1.09M 0.01% 1023
2020
Q1
$27.1M Buy
249,334
+174,876
+235% +$19M 0.01% 1072
2019
Q4
$8.58M Buy
74,458
+11,148
+18% +$1.28M ﹤0.01% 2077
2019
Q3
$5.09M Sell
63,310
-591
-0.9% -$47.5K ﹤0.01% 2516
2019
Q2
$4.64M Buy
63,901
+5,793
+10% +$420K ﹤0.01% 2622
2019
Q1
$5.43M Sell
58,108
-1,164
-2% -$109K ﹤0.01% 2467
2018
Q4
$4.32M Sell
59,272
-140,677
-70% -$10.3M ﹤0.01% 2548
2018
Q3
$17.5M Buy
199,949
+3,146
+2% +$275K ﹤0.01% 1604
2018
Q2
$19.4M Buy
196,803
+78,675
+67% +$7.75M 0.01% 1519
2018
Q1
$14.1M Sell
118,128
-6,170
-5% -$735K ﹤0.01% 1708
2017
Q4
$15.8M Sell
124,298
-11,020
-8% -$1.4M ﹤0.01% 1637
2017
Q3
$15.9M Sell
135,318
-194,298
-59% -$22.8M ﹤0.01% 1590
2017
Q2
$26.3M Sell
329,616
-45,310
-12% -$3.61M 0.01% 1208
2017
Q1
$19.2M Buy
374,926
+95,177
+34% +$4.88M 0.01% 1389
2016
Q4
$10.5M Sell
279,749
-187,750
-40% -$7.03M ﹤0.01% 1808
2016
Q3
$31.7M Sell
467,499
-230,899
-33% -$15.7M 0.01% 997
2016
Q2
$38.8M Sell
698,398
-74,653
-10% -$4.14M 0.02% 888
2016
Q1
$48.5M Sell
773,051
-1,185
-0.2% -$74.4K 0.02% 776
2015
Q4
$72.9M Sell
774,236
-2,640
-0.3% -$249K 0.03% 586
2015
Q3
$62.4M Buy
776,876
+42,219
+6% +$3.39M 0.03% 647
2015
Q2
$88.1M Sell
734,657
-43,368
-6% -$5.2M 0.03% 557
2015
Q1
$81.2M Sell
778,025
-42,090
-5% -$4.4M 0.03% 574
2014
Q4
$79.6M Sell
820,115
-153,674
-16% -$14.9M 0.03% 554
2014
Q3
$76.1M Sell
973,789
-15,910
-2% -$1.24M 0.03% 549
2014
Q2
$62.5M Sell
989,699
-78,830
-7% -$4.98M 0.03% 669
2014
Q1
$71.7M Buy
1,068,529
+70,995
+7% +$4.77M 0.03% 596
2013
Q4
$64.1M Buy
997,534
+30,365
+3% +$1.95M 0.03% 627
2013
Q3
$61.9M Sell
967,169
-107,360
-10% -$6.87M 0.03% 589
2013
Q2
$33.3M Buy
+1,074,529
New +$33.3M 0.02% 843